NOV140101

IDX-1197 · Idience Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NOV140101, covering 2026-04-17 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess the Safety & Tolerability of NOV140101(IDX-1197) in Patients With Advanced Solid Tumors [Phase 1]